| # | Drug | Count |
|---|---|---|
| 0 | LORAZEPAM | 28 |
| 1 | ADALIMUMAB | 23 |
| 2 | TESTOSTERONE | 22 |
| 3 | ROSUVASTATIN | 20 |
| 4 | OMEPRAZOLE MAGNESIUM | 19 |
| 5 | VENLAFAXINE HYDROCHLORIDE | 18 |
| 6 | ACETAMINOPHEN | 17 |
| 7 | CITALOPRAM | 16 |
| 8 | GABAPENTIN | 16 |
| 9 | METHOTREXATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UNCARIA TOMENTOSA | 1 | 0.0082 |
| 1 | CASTOR OIL | 1 | 0.0052 |
| 2 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 3 | PENICILLIN G | 5 | 0.0021 |
| 4 | CLOMIPHENE CITRATE | 3 | 0.0020 |
| 5 | ZOLMITRIPTAN | 11 | 0.0015 |
| 6 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 7 | DRONABINOL | 10 | 0.0012 |
| 8 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 9 | TESTOSTERONE | 22 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 46 |
| 1 | Benzodiazepine [EPC] | 45 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 3 | Androgen [EPC] | 22 |
| 4 | Atypical Antipsychotic [EPC] | 22 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 22 |
| 6 | beta-Adrenergic Blocker [EPC] | 20 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 19 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 19 |
| 9 | Kinase Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Cannabinoid [EPC] | 10 | 0.0012 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Androgen [EPC] | 22 | 0.0008 |
| 4 | Leptin Analog [EPC] | 1 | 0.0008 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 11 | 0.0004 |
| 6 | PCSK9 Inhibitor [EPC] | 9 | 0.0003 |
| 7 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 8 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |